Medeor Therapeutics is a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of personalized cellular immunotherapies to improve outcomes in organ transplant recipients. Medeor's product candidates are designed to produce mixed chimerism to achieve donor-specific immune tolerance and improve patient outcomes.
Market
Organ Transplantation
Location
San Mateo,
California,
USA
Coinvestors
6 Dimensions Capital, RA Capital Management, Sofinnova Ventures, Vivo Capital, WuXi Healthcare Ventures